RBM20 and hypopharynx cancer: In our samples, KMT2C, which participates in protein binding, has pathogenic mutations in all samples, and the expression of RBM20 is related to the survival of patients with hypopharyngeal cancer, indicating that they are likely to be related to the pathogenesis of hypopharyngeal cancer.